Evaluation of Cytogenetic Changes and FLT3 mutations in Patients with Acute Promyelocytic Leukemia

Introduction: The secondary genetic changes other than the PML-RARA fusion gene may contribute to the acute promyelocytic leukemogenesis. Chromosomal alterations and mutation of FLT3 tyrosine kinase receptor are the frequent genetic alterations in acute myeloid leukemia (AML). However, the prognosti...

Full description

Bibliographic Details
Main Authors: Marjan Yaghmaie, Hossein Mozdarani, Kamran Alimoghaddam, Ardeshir Ghavamzadeh, Seyed Hamiollah Ghaffari
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2010-09-01
Series:International Journal of Hematology-Oncology and Stem Cell Research
Subjects:
Online Access:https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/253
_version_ 1797706081209679872
author Marjan Yaghmaie
Hossein Mozdarani
Kamran Alimoghaddam
Ardeshir Ghavamzadeh
Seyed Hamiollah Ghaffari
author_facet Marjan Yaghmaie
Hossein Mozdarani
Kamran Alimoghaddam
Ardeshir Ghavamzadeh
Seyed Hamiollah Ghaffari
author_sort Marjan Yaghmaie
collection DOAJ
description Introduction: The secondary genetic changes other than the PML-RARA fusion gene may contribute to the acute promyelocytic leukemogenesis. Chromosomal alterations and mutation of FLT3 tyrosine kinase receptor are the frequent genetic alterations in acute myeloid leukemia (AML). However, the prognostic significance of FLT3 mutations in acute promyelocytic leukemia (APL) is not firmly established. Patients & Methods: FLT3 ITD screening by fragment length analysis and FLT3 D835 mutation by melting curve analysis in 23 APL samples was screened in this study. Results: About13% of the patients had FLT3 internal tandem duplications (ITDs), and 26% had D835 point mutation. FLT3 ITD mutation was associated with higher white blood cell (WBC) count at presentation and poor prognosis. Conclusions: As the PML-RARA is not sufficient to develop APL, we assume FLT3 mutations and additional chromosomal alterations in this APL series may cooperate with PML-RARA in APL development.
first_indexed 2024-03-12T05:46:53Z
format Article
id doaj.art-ca008dcbc6e6454eae6cbfa785db7ad8
institution Directory Open Access Journal
issn 2008-2207
language English
last_indexed 2024-03-12T05:46:53Z
publishDate 2010-09-01
publisher Tehran University of Medical Sciences
record_format Article
series International Journal of Hematology-Oncology and Stem Cell Research
spelling doaj.art-ca008dcbc6e6454eae6cbfa785db7ad82023-09-03T05:36:13ZengTehran University of Medical SciencesInternational Journal of Hematology-Oncology and Stem Cell Research2008-22072010-09-0143Evaluation of Cytogenetic Changes and FLT3 mutations in Patients with Acute Promyelocytic LeukemiaMarjan Yaghmaie0Hossein Mozdarani1Kamran Alimoghaddam2Ardeshir Ghavamzadeh3Seyed Hamiollah Ghaffari4Medical Genetics Department, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, IranMedical Genetics Department, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, IranHematology, Oncology and Stem Cell Transplantation Research Center, Shariati Hospital, Tehran University, Tehran, IranHematology, Oncology and Stem Cell Transplantation Research Center, Shariati Hospital, Tehran University, Tehran, IranHematology, Oncology and Stem Cell Transplantation Research Center, Shariati Hospital, Tehran University, Tehran, IranIntroduction: The secondary genetic changes other than the PML-RARA fusion gene may contribute to the acute promyelocytic leukemogenesis. Chromosomal alterations and mutation of FLT3 tyrosine kinase receptor are the frequent genetic alterations in acute myeloid leukemia (AML). However, the prognostic significance of FLT3 mutations in acute promyelocytic leukemia (APL) is not firmly established. Patients & Methods: FLT3 ITD screening by fragment length analysis and FLT3 D835 mutation by melting curve analysis in 23 APL samples was screened in this study. Results: About13% of the patients had FLT3 internal tandem duplications (ITDs), and 26% had D835 point mutation. FLT3 ITD mutation was associated with higher white blood cell (WBC) count at presentation and poor prognosis. Conclusions: As the PML-RARA is not sufficient to develop APL, we assume FLT3 mutations and additional chromosomal alterations in this APL series may cooperate with PML-RARA in APL development.https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/253Acute promyelocytic leukemiaFLT3 tyrosine kinaseInternal tandem duplication
spellingShingle Marjan Yaghmaie
Hossein Mozdarani
Kamran Alimoghaddam
Ardeshir Ghavamzadeh
Seyed Hamiollah Ghaffari
Evaluation of Cytogenetic Changes and FLT3 mutations in Patients with Acute Promyelocytic Leukemia
International Journal of Hematology-Oncology and Stem Cell Research
Acute promyelocytic leukemia
FLT3 tyrosine kinase
Internal tandem duplication
title Evaluation of Cytogenetic Changes and FLT3 mutations in Patients with Acute Promyelocytic Leukemia
title_full Evaluation of Cytogenetic Changes and FLT3 mutations in Patients with Acute Promyelocytic Leukemia
title_fullStr Evaluation of Cytogenetic Changes and FLT3 mutations in Patients with Acute Promyelocytic Leukemia
title_full_unstemmed Evaluation of Cytogenetic Changes and FLT3 mutations in Patients with Acute Promyelocytic Leukemia
title_short Evaluation of Cytogenetic Changes and FLT3 mutations in Patients with Acute Promyelocytic Leukemia
title_sort evaluation of cytogenetic changes and flt3 mutations in patients with acute promyelocytic leukemia
topic Acute promyelocytic leukemia
FLT3 tyrosine kinase
Internal tandem duplication
url https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/253
work_keys_str_mv AT marjanyaghmaie evaluationofcytogeneticchangesandflt3mutationsinpatientswithacutepromyelocyticleukemia
AT hosseinmozdarani evaluationofcytogeneticchangesandflt3mutationsinpatientswithacutepromyelocyticleukemia
AT kamranalimoghaddam evaluationofcytogeneticchangesandflt3mutationsinpatientswithacutepromyelocyticleukemia
AT ardeshirghavamzadeh evaluationofcytogeneticchangesandflt3mutationsinpatientswithacutepromyelocyticleukemia
AT seyedhamiollahghaffari evaluationofcytogeneticchangesandflt3mutationsinpatientswithacutepromyelocyticleukemia